Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 1
1976 4
1977 3
1978 2
1979 5
1980 5
1981 5
1982 7
1983 7
1984 9
1985 14
1986 13
1987 13
1988 22
1989 21
1990 31
1991 49
1992 40
1993 40
1994 65
1995 70
1996 84
1997 84
1998 72
1999 103
2000 109
2001 147
2002 132
2003 184
2004 185
2005 218
2006 231
2007 243
2008 276
2009 299
2010 364
2011 394
2012 430
2013 483
2014 487
2015 486
2016 548
2017 586
2018 638
2019 738
2020 812
2021 792
2022 698
2023 656
2024 262

Text availability

Article attribute

Article type

Publication date

Search Results

9,771 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Advanced Lung Small Cell Carcinoma"
Page 1
Small-cell lung cancer.
Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Rudin CM, et al. Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0. Nat Rev Dis Primers. 2021. PMID: 33446664 Free PMC article. Review.
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high proliferative rate, strong predilection for early metastasis and poor prognosis. ...The recent introduction of immune checkpoint blocka …
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high pr …
Lung cancer.
Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Thai AA, et al. Lancet. 2021 Aug 7;398(10299):535-554. doi: 10.1016/S0140-6736(21)00312-3. Epub 2021 Jul 21. Lancet. 2021. PMID: 34273294 Review.
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1.76 million deaths per year. ...This seminar provides an overview of advances in the screening, diagnosis, …
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimate …
Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review.
Petty WJ, Paz-Ares L. Petty WJ, et al. JAMA Oncol. 2023 Mar 1;9(3):419-429. doi: 10.1001/jamaoncol.2022.5631. JAMA Oncol. 2023. PMID: 36520421 Review.
IMPORTANCE: Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early development of metastases. ...Ongoing research has advanced the understanding of molecular categories and the immunologic microenviro …
IMPORTANCE: Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early …
Classification and Pathology of Lung Cancer.
Zheng M. Zheng M. Surg Oncol Clin N Am. 2016 Jul;25(3):447-68. doi: 10.1016/j.soc.2016.02.003. Surg Oncol Clin N Am. 2016. PMID: 27261908 Review.
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, reflected in the recently introduced 2015 World Health Organization classification of lung cancer. ...In resection specimens, adenocarcin …
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, refl …
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q, Zhang J, Guo C, Wang M, Wang C, Yan Y, Sun L, Wang D, Zhang L, Yu H, Hou L, Wu C, Zhu Y, Jiang G, Zhu H, Zhou Y, Fang S, Zhang T, Hu L, Li J, Liu Y, Zhang H, Zhang B, Ding L, Robles AI, Rodriguez H, Gao D, Ji H, Zhou H, Zhang P. Liu Q, et al. Cell. 2024 Jan 4;187(1):184-203.e28. doi: 10.1016/j.cell.2023.12.004. Cell. 2024. PMID: 38181741
We performed comprehensive proteogenomic characterization of small cell lung cancer (SCLC) using paired tumors and adjacent lung tissues from 112 treatment-naive patients who underwent surgical resection. Integrated multi-omics analysis illustrated can …
We performed comprehensive proteogenomic characterization of small cell lung cancer (SCLC) using paired tumors and adja …
Small cell lung cancer transformation: From pathogenesis to treatment.
Yin X, Li Y, Wang H, Jia T, Wang E, Luo Y, Wei Y, Qin Z, Ma X. Yin X, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):595-606. doi: 10.1016/j.semcancer.2022.03.006. Epub 2022 Mar 8. Semin Cancer Biol. 2022. PMID: 35276343 Review.
Small cell lung cancer (SCLC) is a type of neuroendocrine tumor with high malignancy and poor prognosis. ...Although SCLC transformation is not common in clinical practice, it has been repeatedly identified in many small patient series and case …
Small cell lung cancer (SCLC) is a type of neuroendocrine tumor with high malignancy and poor prognosis. ...Alth …
Immunotherapy in Lung Cancer: Current Landscape and Future Directions.
Mamdani H, Matosevic S, Khalid AB, Durm G, Jalal SI. Mamdani H, et al. Front Immunol. 2022 Feb 9;13:823618. doi: 10.3389/fimmu.2022.823618. eCollection 2022. Front Immunol. 2022. PMID: 35222404 Free PMC article. Review.
Immune checkpoint inhibitors (ICIs) have shown tremendous benefit in the treatment of non-small cell lung cancer (NSCLC) and are now being used as first-line therapies in metastatic disease, consolidation therapy following chemoradiation in unresectable local …
Immune checkpoint inhibitors (ICIs) have shown tremendous benefit in the treatment of non-small cell lung cancer (NSCLC …
Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment.
Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G. Zhu Y, et al. Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166557. doi: 10.1016/j.bbadis.2022.166557. Epub 2022 Sep 24. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 36162624 Free article. Review.
However, small-cell lung cancer (SCLC) accounts for 14 % of all lung cancer cases. ...Additionally, it provided in-depth information on the recent advances in SCLC treatments, and highlighted several new models and biomarkers with promises to im …
However, small-cell lung cancer (SCLC) accounts for 14 % of all lung cancer cases. ...Additionally, it provided …
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X, Chen L, Li Y, Hu Z, He F. Niu X, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):273-285. doi: 10.1016/j.semcancer.2022.03.009. Epub 2022 Mar 12. Semin Cancer Biol. 2022. PMID: 35288298 Review.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer characterized by dismal prognosis. ...In the present review, we summarize the roles of distinct ICD mechanisms on antitumor immunity and recent advances of ferroptosis-, n …
Small cell lung cancer (SCLC) is an aggressive form of lung cancer characterized by dismal prognosis. ... …
Overcoming Chemotherapy Resistance in SCLC.
Herzog BH, Devarakonda S, Govindan R. Herzog BH, et al. J Thorac Oncol. 2021 Dec;16(12):2002-2015. doi: 10.1016/j.jtho.2021.07.018. Epub 2021 Aug 3. J Thorac Oncol. 2021. PMID: 34358725 Free article. Review.
SCLC is an aggressive form of lung cancer with a very poor prognosis. Although SCLC initially responds very well to platinum-based chemotherapy, it eventually recurs and at recurrence is nearly universally resistant to therapy. In light of the recent advances …
SCLC is an aggressive form of lung cancer with a very poor prognosis. Although SCLC initially responds very well to platinum-b …
9,771 results